Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multi-omics spatial characteristics of CD8<sup>+</sup>TRM cells in hepatocellular carcinoma and immunotherapy response prediction.

Frontiers in immunology·2025

Same author

Intratumoral microbiota remodeling of the tumor microenvironment impact solid tumor immunotherapy.

Cell death & disease·2025

Same author

m7G RNA methylation in cancer: Effect, mechanism and clinical application.

Clinical and translational medicine·2025

Same author

Single-cell transcriptomics reveals hypoxia-driven iCAF_PLAU is associated with stemness and immunosuppression in anorectal malignant melanoma.

Journal of gastroenterology·2025

Same author

Spatial omics technology potentially promotes the progress of tumor immunotherapy.

British journal of cancer·2025

Same author

Regulatory T cells in solid tumor immunotherapy: effect, mechanism and clinical application.

Cell death & disease·2025

Search research articles

Related Experiment Video

Updated: Aug 6, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Engineered exosomes from different sources for cancer-targeted therapy.

Menghui Zhang¹, Shengyun Hu², Lin Liu^3,4

¹Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450001, China.

Signal Transduction and Targeted Therapy

|March 16, 2023

Summary

Engineered exosomes offer targeted cancer therapy by delivering drugs precisely. This review explores their development, modification, and application in cancer treatment, aiming to accelerate clinical use.

More Related Videos

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

Related Experiment Videos

Last Updated: Aug 6, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

Area of Science:

Biomedical Engineering
Nanotechnology
Cancer Therapy

Background:

Exosomes, a type of extracellular vesicle, are potent therapeutic tools for diseases.
Engineered exosomes, modified for enhanced drug delivery, show promise in cancer treatment with reduced side effects.

Purpose of the Study:

To review recent advances in engineered exosomes for cancer therapy.
To address challenges in clinical translation and identify optimal strategies for antitumor activity.

Main Methods:

Summarizing characteristics, especially spatial and temporal properties, of engineered exosomes.
Reviewing sources, isolation technologies, modification strategies, and labeling/imaging methods.
Analyzing applications in photodynamic, gene, and immunotherapy.

Main Results:

Engineered exosomes can be precisely modified for targeted drug delivery to tumors.
Various strategies exist for exosome modification and application in different cancer therapies.
Understanding spatial and temporal properties is crucial for efficacy.

Conclusions:

Engineered exosomes hold significant potential for targeted cancer therapy.
Further research into modification strategies and source selection is needed for clinical translation.
This review provides insights for developing new drug delivery systems and accelerating clinical applications.